Literature DB >> 9870617

The non-specific effect of endolymphatic sac surgery in treatment of Meniere's disease: a prospective, randomized controlled study comparing "classic" endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane.

J Thomsen1, P Bonding, B Becker, J Stage, M Tos.   

Abstract

A prospective, randomized study was carried out comparing the effect of two surgical modalities in the treatment of patients with Meniere's disease: insertion of an endolymphatic sac shunt and insertion of a ventilating tube in the tympanic membrane. A total of 29 patients, 12 males and 17 females, age 27-71 years, were operated on in two ear, nose and throat (ENT) departments. Of these patients, 15 had an endolymphatic shunt inserted and 14 had a ventilating tube inserted in the tympanic membrane. Postoperative follow-up was carried out in the department in which the patients had not been operated. The severity of the disease was scored pre- and postoperatively, and the results evaluated under the guidelines of the Committee on Hearing and Equilibrium (1995) for the diagnosis and evaluation of therapy in Meniere's disease. The patients in both groups had a statistically significant reduction in dizzy spells, measured 6 and 12 months postoperatively, and there was no difference between the groups. The pathophysiological explanation for the reduction in dizzy spells in each of the treatment modalities is debatable and the effect is non-specific. The patients' hearing and tinnitus were statistically unaffected by the treatment in both groups, though 2 patients in the shunt group developed severe hearing loss (anacusis/70 dB).

Entities:  

Mesh:

Year:  1998        PMID: 9870617     DOI: 10.1080/00016489850182413

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  14 in total

1.  [Transtympanic administration of gentamicin in Menière diseases--less is more!?].

Authors:  A Koitschev
Journal:  HNO       Date:  2003-11       Impact factor: 1.284

Review 2.  Current evidence for endolymphatic sac surgery in the treatment of Meniere's disease: a systematic review.

Authors:  Ming Yann Lim; Margaret Zhang; Heng Wai Yuen; Jern-Lin Leong
Journal:  Singapore Med J       Date:  2015-11       Impact factor: 1.858

3.  [Indications for operative therapy of vestibular vertigo and the associated success rates].

Authors:  M Westhofen
Journal:  HNO       Date:  2013-09       Impact factor: 1.284

Review 4.  Menière's disease: pathophysiology and treatment.

Authors:  H Thai-Van; M J Bounaix; B Fraysse
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Vestibular and audiometric results after endolymphatic mastoid shunt surgery in patients with Menière's disease.

Authors:  Jennifer L Spiegel; Ivelina Stoycheva; Bernhard G Weiss; Mattis Bertlich; Tobias Rader; Martin Canis; Friedrich Ihler
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-08-15       Impact factor: 3.236

6.  Procedures for restoring vestibular disorders.

Authors:  Leif Erik Walther
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

Review 7.  Recent surgical options for vestibular vertigo.

Authors:  Stefan Volkenstein; Stefan Dazert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

Review 8.  Rare causes of emesis.

Authors:  Stefan L Popa; Giuseppe Chiarioni; Liliana David; George I Golea; Dan L Dumitrascu
Journal:  Med Pharm Rep       Date:  2020-04-22

9.  CT imaging of the Eustachian tube using focal contrast medium administration: a feasibility study in humans.

Authors:  Benedicte Falkenberg-Jensen; Greg E Jablonski; Juha T Silvola; Joanna F Kristiansen; Einar Hopp
Journal:  Acta Radiol Open       Date:  2020-01-22

10.  A Two-Year Randomized Trial of Interventions to Decrease Stress Hormone Vasopressin Production in Patients with Meniere's Disease-A Pilot Study.

Authors:  Tadashi Kitahara; Hidehiko Okamoto; Munehisa Fukushima; Masaharu Sakagami; Taeko Ito; Akinori Yamashita; Ichiro Ota; Toshiaki Yamanaka
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.